Press Releases

Filter by

10 Jun 2025

ClavystBio

ClavystBio and ASTAR Partner to Grow MedTech Ventures in Singapore

05 Jun 2025

Portfolio

Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line to Advance ATX101 and its Ultra-Sustained Pain Platform for Post-Surgical Pain Management

03 Mar 2025

Portfolio

Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept

22 Jan 2025

Portfolio

CoV Biotechnology Takes Next Step to Become Leyden Labs Asia, Advancing its Mission to Combat Respiratory Infectious Diseases

09 Jan 2025

Portfolio

Leyden Labs Raises $70M to Advance its Intranasal Antibody Programs to Protect against Influenza and other Viruses

11 Apr 2024

Portfolio

Allay Therapeutics’ Phase 2B Clinical Study Supports Ability of ATX101 To Deliver Four Weeks of Sustained Post-surgical Pain Relief

18 Dec 2023

Portfolio

Allay Therapeutics Announces Development and Commercialization Agreement with Maruishi Pharmaceutical for Ultra-Sustained Pain Therapeutics in Japan

31 Oct 2023

Portfolio

Engine Biosciences Secures $27 Million Series A Extension to Advance Development of Precision Oncology Medicines and Novel Biomarkers for Patient Selection

23 Oct 2023

Portfolio

Hummingbird Bioscience Announces Positive Phase I Clinical Data for HMBD-001 Monotherapy Trial at the European Society for Medical Oncology Congress 2023

20 Oct 2023

Portfolio

Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501

Stay in the Loop

Sign up to get the latest news on our innovation community and events.

Subscribe Now